Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Emily Wesson"'
Autor:
Emily Wesson, Paolo Strati, Luis Fayad, Michelle A. Fanale, Charnelle Ruben, Loretta J. Nastoupil, Michael Wang, Richard E. Davis, Larry W. Kwak, Richard Piekarz, Yasuhiro Oki, Fredrick B. Hagemeister, Jason R. Westin, Hun Ju Lee, Nathan Fowler
Publikováno v:
Haematologica. 105:e26-e28
Autor:
Michelle A. Fanale, Chitra Hosing, Charnelle Ruben, Naveen Garg, Yasuhiro Oki, Yago Nieto, Paolo Strati, Rammurti T. Kamble, Issa F. Khouri, Loretta J. Nastoupil, Felipe Samaniego, Nathan Fowler, Dai Chihara, Mildred D. Stafford, Luis Fayad, Emily Wesson, Lei Feng, Jorge E. Romaguera, Sandra B. Horowitz
Publikováno v:
Haematologica. 103:e416-e418
The survival outcome of patients with peripheral T-cell lymphoma (PTCL) who experience relapse or progression following first-line treatment is generally very poor.[1][1] It can improve for patients who are able to receive stem cell transplantation (
Autor:
Sheeba K. Thomas, Jatin J. Shah, Donna M. Weber, Ashley Morphey, Hans C. Lee, Robert Z. Orlowski, Michael L. Wang, Emily Wesson, Ralph J. Johnson, Lei Feng, Raymond Alexanian
Publikováno v:
American Journal of Hematology. 94
Autor:
Nathan Fowler, Jorge E. Romaguera, Feng Lei, Yasuhiro Oki, Hubert H. Chuang, Sandra B. Horowitz, Charnelle Ruben, Luis Fayad, Richard Piekarz, Dai Chihara, Tariq Muzzafar, Wencai Ma, Toni Hutto, Michelle A. Fanale, Felipe Samaniego, Emily Wesson, R. Eric Davis, Nina Shah, Fredrick B. Hagemeister, Zhiqiang Wang
Publikováno v:
Blood. 126:2705-2705
Background: The histone deacetylase inhibitor (HDACi) romidepsin (Coiffier 2010) and other HDACi such as belinostat (O'Connor 2015) are management options for relapsed peripheral T-cell lymphoma (PTCL), and HDACi have also shown benefit for B-cell ly
Autor:
Jorge E. Romaguera, Luis Fayad, Loretta J. Nastoupil, Felipe Samaniego, Issa F. Khouri, Emily Wesson, Lei Feng, Yasuhiro Oki, Naveen Garg, Michelle A. Fanale, Chitra Hosing, Jason R. Westin, Sandra B. Horowitz, Charnelle Ruben, Dai Chihara, Nathan Fowler, Sairah Ahmed
Publikováno v:
Blood. 126:3987-3987
Background: Survival for patients with relapsed/refractory peripheral T-cell lymphoma (PTCL) remains very poor. Outcomes for these patients may be improved by stem cell transplant particularly if in complete remission (CR) prior to transplant (Smith
Autor:
Issa F. Khouri, Sairah Ahmed, Dai Chihara, Yasuhiro Oki, Charnelle Ruben, Naveen Garg, Joseph E Woolery, Michelle A. Fanale, Luis Fayad, Sandra B. Horowitz, Emily Wesson, Lei Feng
Publikováno v:
Blood. 124:1748-1748
Background: Despite recent approval of 4 new drugs for relapsed PTCL, an unmet need remains for new therapies. Survival of relapsed/refractory PTCL patients is improved by stem cell transplant particularly if patients are in CR prior to transplant (S
Autor:
Michelle A. Fanale, Fredrick B. Hagemeister, Luis Fayad, Yasuhiro Oki, Nathan Fowler, Jorge Romaguera, Nina Shah, Hubert Chuang, Lei Feng, Sandra B Horowitz, Emily Wesson, Toni Y Hutto, Tariq Muzzafar, Felipe Samaniego, R Eric Davis
Publikováno v:
Blood. 124:1744-1744
Background: The histone deacetylase inhibitor (HDACi) romidepsin, while a clear advance for relapsed peripheral and cutaneous T cell lymphomas (CTCL and PTCL), induces short durations of remission at 9 to 10 months (Piekarz et al., 2011 and Coiffier